We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RNLX market cap is 74.09M. The company's latest EPS is USD -0.4929 and P/E is -0.49.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.19M | 724k | 518k | 459k | 709k |
| Operating Income | -5.98M | -14.8M | -413k | -8.89M | -3.8M |
| Net Income | -10.69M | -11.86M | -11.72M | -10.15M | -9.13M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 339k | 1.49M | 2.97M | 3.4M |
| Operating Income | -6.96M | -10.8M | -34.72M | -57.24M | -32.19M |
| Net Income | -5.98M | -9.25M | -31.01M | -56.73M | -46.22M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.61M | 39.8M | 42.12M | 19.54M | 21.87M |
| Total Liabilities | 21.81M | 21.71M | 23.66M | 21.03M | 19.21M |
| Total Equity | 20.81M | 18.1M | 18.45M | -1.49M | 2.67M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.92M | 41.3M | 102.58M | 63.26M | 42.12M |
| Total Liabilities | 755k | 5.34M | 7.48M | 20.09M | 23.66M |
| Total Equity | 28.17M | 35.96M | 95.1M | 43.17M | 18.45M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.28M | -25.45M | -32.67M | -9.5M | -17.35M |
| Investing | -64k | -59k | N/A | N/A | N/A |
| Financing | -1.03M | 16.48M | 15.12M | -1.07M | -1.65M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.42M | -10.06M | -24.63M | -45.75M | -32.67M |
| Investing | -13.05M | -849k | -741k | -694k | N/A |
| Financing | 26.74M | 16.85M | 77.24M | 25.52M | 15.12M |
| Market Cap | 74.09M |
| Price to Earnings Ratio | -0.49 |
| Price to Sales Ratio | 6.61 |
| Price to Cash Ratio | 0.91 |
| Price to Book Ratio | 1.22 |
| Dividend Yield | - |
| Shares Outstanding | 93.78M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (5%) |
| Company Name | Renalytix PLC |
| Address |
finsgate london EC1V 9EE |
| Website | https://renalytix.com |
| Industry | services, nec (8999) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
